SALT LAKE CITY, UT / ACCESS Newswire / September 25, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) is offering to purchase up to 650,000 shares of its common stock at $75.00 per share. The conditions of the Offer are explained in detail in the SEC Form TO Offer to Purchase and Letter of Transmittal filed with the SEC at
https://www.sec.gov/Archives/edgar/data/706698/000109690626001428/0001096906-26-001428-index.html
The Offer is scheduled to expire at 5:00 p.m. New York City time, on October 7, unless extended by UTMD. October 7 is a Wednesday. Some of UTMD’s previous announcements indicated incorrectly that October 7 is a Tuesday.
The Company regrets any confusion caused by the error.
Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long-term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD’s website at www.utahmed.com.
Contact:
Brian Koopman
(801) 566-1200
SOURCE: Utah Medical Products, Inc.
View the original press release on ACCESS Newswire
PUNE, India, Sept. 25, 2026 /PRNewswire/ -- The Global AI in Clinical Trials Market was valued…
HILLSIDE, NJ / ACCESS Newswire / September 25, 2026 / Integrated BioPharma, Inc. (OTCQX:INBP) (the…
KENAI, Alaska, Sept. 25, 2026 /PRNewswire/ -- The Kenaitze Indian Tribe ("KIT") has learned of…
Mequon, Wisconsin--(Newsfile Corp. - September 25, 2026) - Vector Science and Therapeutics Corp. (TSXV: PAIN)…
Engineered 20-nanometer surface architecture on Innovasis' HA-coated titanium implants was reviewed and cleared under the…
The expansion adds a harm-from-others safety area to VERA-MH, the first open-source AI safety benchmark…